Home
News
Create
Screeners
Insights
Ganga Pharmaceuticals
11.
68
-11.68
(-100.00%)
Market Cap
₹9.90 Cr
PE Ratio
488.20
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-100.00%
1M
-100.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Ganga Pharmaceuticals
Ganga Pharmaceuticals Reports Decline in Revenue and Profit for H1 FY2026
Nov 07, 2025
Ganga Pharmaceuticals Limited, an Ayurvedic products company, released unaudited financial results for H1 FY2026 ending September 30, 2025. Revenue from operations decreased by 48.19% to Rs. 136.65 lakhs, while net profit fell by 68.61% to Rs. 2.48 lakhs compared to H1 FY2025. The company converted 10,75,000 warrants into equity shares, raising Rs. 112.88 lakhs and increasing paid-up equity share capital to Rs. 591.15 lakhs. Total assets rose to Rs. 1,016.21 lakhs, and shareholders' funds increased to Rs. 828.50 lakhs as of September 30, 2025.
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant Conversion
Sep 19, 2025
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant Conversion
Aug 05, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation